During the past decade, Juntendo University Hospital conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 25 clinical trials were completed, i.e. on average, 42.4% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 18 clinical trials were completed. i.e. 62.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Juntendo University Hospital" #1 sponsor was "Boehringer Ingelheim" with 10 trials, followed by "Hoffmann-La Roche" with 10 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Pfizer" with 5 trials sponsored and "Actelion" with 5 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Juntendo University Hospital" #1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Grifols Japan K.K." with 2 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials as a collaborator and "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Juntendo University Hospital" are "Alzheimer Disease" (6 trials), "Non-Small Cell Lung Cancer" (4 trials), "Heart Failure" (3 trials), "Myelofibrosis" (3 trials) and "Alpha1-Antitrypsin Deficiency" (2 trials). Many other conditions were trialed in "Juntendo University Hospital" in a lesser frequency.

Most popular intervention types in "Juntendo University Hospital" are "Drug" (58 trials), "Biological" (7 trials), "Device" (5 trials), "Other" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Cisplatin" (7 trials), "Pemetrexed" (7 trials), "Carboplatin" (5 trials) and "Gemcitabine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Juntendo University Hospital" are 69 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Juntendo University Hospital". undefined are not yet recruiting, 15 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Juntendo University Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Juntendo University Hospital, 4 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".

Juntendo University Hospital has several departments that took part in Clinical trials: "Juntendo University Hospital; Neurology" - 4 trials